Shanghai Medicilon Inc. (SHA:688202)
74.22
-5.88 (-7.34%)
Nov 16, 2026, 4:00 PM EST
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 9.76 billion as of November 16, 2026. It is the 7,867th most valuable company in the world and the 1,536th biggest in China. Its market cap has increased by 11.69% in one year.
Market Cap
9.76B
Enterprise Value
9.46B
Revenue
1.54B
Global Rank
Country Rank
#1,536 China
PE Ratio
n/a
ChartMarket Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 9.76B, an increase of 121.79%. That is a compound annual growth rate of 11.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 9.76B | 31.60% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inner Mongolia Furui Medical Science | 11.47B |
| Nanjing Vazyme Biotech | 10.89B |
| Chengdu Olymvax Biopharmaceuticals | 10.82B |
| Tibet Cheezheng Tibetan Medicine | 10.50B |
| Novoprotein Scientific | 9.40B |
| Chongqing Genrix Biopharmaceutical | 9.28B |
| Shanghai OPM Biosciences | 9.23B |
| Staidson (Beijing) BioPharmaceuticals | 9.22B |